NASDAQ · CABA
Cabaletta Bio, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CABA: Nov 9, 2026
Cabaletta Bio, Inc. Common Stock is estimated to report earnings on 11/09/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.33. The reported EPS for the same quarter last year was $-0.44.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.33 | $-0.31 | $-0.34 | 3 |
| Dec 2026 | $-0.34 | $-0.31 | $-0.35 | 3 |
| Mar 2027 | $-0.31 | $-0.31 | $-0.31 | 1 |
| Jun 2027 | $-0.31 | $-0.31 | $-0.31 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest · RTTNews · Fintel- Zacks · May 20, 9:40 AM EDTIs Cabaletta Bio (CABA) Stock Outpacing Its Medical Peers This Year?Here is how Cabaletta Bio, Inc. (CABA) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.
- Zacks · May 18, 12:00 PM EDTCabaletta Bio (CABA) Upgraded to Buy: Here's WhyCabaletta Bio (CABA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks · Mar 6, 12:00 PM ESTCabaletta Bio (CABA) Upgraded to Buy: Here's What You Should KnowCabaletta Bio (CABA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks · Mar 3, 9:40 AM ESTAre Medical Stocks Lagging Biodesix (BDSX) This Year?Here is how Biodesix, Inc. (BDSX) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
- Zacks · Feb 12, 9:40 AM ESTIs Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?Here is how Anavex Life Sciences (AVXL) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
- Zacks · Jan 30, 12:00 PM ESTWhat Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now?Does Cabaletta Bio, Inc. (CABA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks · Jan 27, 9:40 AM ESTIs Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?Here is how Cabaletta Bio, Inc. (CABA) and Celcuity, Inc. (CELC) have performed compared to their sector so far this year.
- BNK Invest · Jan 22, 10:34 AM ESTThursday 1/22 Insider Buying Report: CMC, CABABargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we
- RTTNews · Jan 21, 11:12 PM ESTBiotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow(RTTNews) – Biotech and healthcare names were among the notable movers in Wednesday's after-hours trading session, with several small-cap companies posting sharp gains.
- RTTNews · Jan 20, 5:30 AM ESTCabaletta To Report Data From RESET Program In Autoimmune Diseases In 1H26; Stock Up 6%(RTTNews) – Shares of Cabaletta Bio, Inc. (CABA) are up nearly 6% at $2.33 in premarket trading on Tuesday.
- Fintel · Dec 6, 8:35 AM ESTCabaletta Bio (CABA) Price Target Increased by 15.31% to 14.41The average one-year price target for Cabaletta Bio (NasdaqGS:CABA) has been revised to $14.41 / share. This is an increase of 15.31% from the prior estimate of $12.50 dated November 14, 2025. The price target is an average of many targets provided by analysts
- Zacks · Nov 4, 9:40 AM ESTIs AtriCure (ATRC) Outperforming Other Medical Stocks This Year?Here is how AtriCure (ATRC) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Cabaletta Bio, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.